Form4insider filings, from the source

SEC Form 4 · accession 0001562180-18-003983

REGENXBIO Inc. · RGNX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kenneth T. Mills
Officer — President and CEO · Director
Period of report
Sep 17, 2018
Accepted (ET)
Sep 19, 2018 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Sep 17, 2018S1,515$70.46D339,505D
Common StockSep 17, 2018S100$71.10D339,405D
Common StockF3Sep 17, 2018S624$73.04D338,781D
Common StockF4Sep 17, 2018S1,399$73.80D337,382D
Common StockF5Sep 17, 2018S622$75.29D336,760D
Common StockF6Sep 17, 2018S1,450$76.72D335,310D
Common StockF7Sep 17, 2018S900$77.88D334,410D
Common StockF8Sep 17, 2018S400$78.73D334,010D
Common StockF9Sep 17, 2018S200$79.45D333,810D
Common StockF10Sep 17, 2018S300$81.12D333,510D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses